Oncology (all articles)
Review: Immune Checkpoint Inhibitors-induced Endocrinopathies in Cancer Patients
25 Feb, 2019 | 00:55h | UTCRelated Guidelines: Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline (free) AND Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group (free)
German Guidelines on the Prevention of Cervical Cancer
25 Feb, 2019 | 01:00h | UTCPart 2: Triage, Treatment and Follow-up
Randomized Trial: Laparoscopic Distal Gastrectomy vs Open Distal Gastrectomy in Patients With Stage I Gastric Cancer
25 Feb, 2019 | 00:47h | UTCEffect of Laparoscopic Distal Gastrectomy vs Open Distal Gastrectomy on Long-term Survival Among Patients With Stage I Gastric Cancer: The KLASS-01 Randomized Clinical Trial – JAMA Oncology (link to abstract – $ for full-text)
Commentary: Laparoscopic distal gastrectomy safe alternative to open surgery – MDedge Hematology & Oncology (free)
LI-RADS: A Conceptual and Historical Review From its Beginning to its Recent Integration Into AASLD Clinical Practice Guidance
25 Feb, 2019 | 00:42h | UTCRelated Guideline: Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases (free)
Randomized Trial: Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy
25 Feb, 2019 | 00:45h | UTCQuality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase 3 Randomized Clinical Trial – JAMA Oncology (link to abstract – $ for full-text)
Commentaries: Hypofractionated RT should be considered new practice standard for men with low risk prostate cancer – NRG Oncology (free) AND Hypofractionated Radiation for Low Risk Prostate Cancer Saves Time and Money – MedicalResearch.com (free)
AHA Scientific Statement on Cardio-Oncology: Vascular and Metabolic Perspectives
22 Feb, 2019 | 01:34h | UTCRelated Guidelines and Reviews: SEOM clinical guidelines on cardiovascular toxicity (2018) – Clinical and Translational Oncology (free) AND Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline (free) AND 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines (free) AND Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy (free) AND Cardio-Onco-Hematology in Clinical Practice. Position Paper and Recommendations – Revista Espanola de Cardiologia (free) AND Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management – CA: A Cancer Journal for Clinicians (free)
Cancer-associated Stroke: Pathophysiology, Detection and Management
22 Feb, 2019 | 01:25h | UTC
USPSTF Draft Statement: BRCA-Related Cancer Risk Assessment, Genetic Counseling, and Genetic Testing
21 Feb, 2019 | 03:59h | UTCDraft Recommendation Statement: BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing – U.S. Preventive Services Task Force (free)
Commentaries: USPSTF Issues Draft Recommendation on BRCA Risk Assessment and Testing – NEJM Journal Watch (free) AND New recommendations say not all women need genetic testing for cancer. Critics say it could cost lives – CNN (free)
SEOM Guideline: Diagnosis and Treatment of Gastroenteropancreatic and Bronchial Neuroendocrine Neoplasm
18 Feb, 2019 | 20:20h | UTC
Expert Consensus on Multidisciplinary Therapy of Colorectal Cancer with Lung Metastases
18 Feb, 2019 | 20:16h | UTC
Review: Managing Malignant Pleural Effusion
17 Feb, 2019 | 20:00h | UTCManaging malignant pleural effusion – Cleveland Clinic Journal of Medicine (free)
Related Guidelines: Management of Malignant Pleural Effusions. An Official ATS/STS/STR Clinical Practice Guideline – American Journal of Respiratory and Critical Care Medicine (free) AND ERS/EACTS statement on the management of malignant pleural effusions – European Respiratory Journal (free)
Meta-Analysis: Risk of Pneumonitis and Pneumonia Associated With Immune Checkpoint Inhibitors for Solid Tumors
16 Feb, 2019 | 19:52h | UTCRelated: Severe Toxicity from Checkpoint Protein Inhibitors (free guidelines and reviews on the subject)
German Guidelines for Cutaneous Basal Cell Carcinoma – Part 2
16 Feb, 2019 | 18:21h | UTCSee also: Guidelines for Cutaneous Basal Cell Carcinoma – Part 1: Epidemiology, Genetics and Diagnosis (free)
Review: The Role of Radiotherapy in Localized and Locally Advanced Prostate Cancer
16 Feb, 2019 | 18:19h | UTC
Review: Diagnosis of Prostate Cancer
16 Feb, 2019 | 18:18h | UTCDiagnosis of Prostate Cancer – Asian Journal of Urology (free)
Viewpoint: Patients and Physicians in the Era of Modern Cancer Care
16 Feb, 2019 | 14:21h | UTCPatients and Physicians in the Era of Modern Cancer Care – JAMA (free for a limited period)
Breast Cancer Deaths Averted Over 3 Decades
14 Feb, 2019 | 01:23h | UTCBreast cancer deaths averted over 3 decades – Cancer (free)
Commentaries: Treatment Advances Averted More Than Half a Million Breast Cancer Deaths Over 3 Decades – AJMC (free) AND Recent Decrease in Deaths Attributable to Breast Cancer in the United States – The ASCO Post (free)
Severe Toxicity from Checkpoint Protein Inhibitors: What Intensive Care Physicians Need to Know?
13 Feb, 2019 | 02:02h | UTCRelated Review: New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management – Critical Care (free)
Related Guidelines: Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline (free) AND Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group (free)
Study: More Low-risk Prostate Cancer Patients Opting for Active Surveillance
13 Feb, 2019 | 01:40h | UTCCommentaries: Study finds upsurge in ‘active surveillance’ for low-risk prostate cancer – Dana-Farber Cancer Institute (free) AND Prostate Cancer Active Surveillance Increasing in the US – Renal & Urology News (free) AND Conservative management of low-risk prostate cancer increasing in USA – medwire News (free) AND More men with low-risk prostate cancer are forgoing treatment, study finds – CNN (free)
UK Consensus Statement: Best Practice in Active Surveillance for Men with Prostate Cancer
13 Feb, 2019 | 01:33h | UTCRelated Guidelines: Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement – Journal of Clinical Oncology (free) AND Active surveillance for the management of localized prostate cancer: Guideline recommendations – Canadian Urological Association Journal (free)
Related Randomized Trial: Radical Prostatectomy vs. Watchful Waiting in Prostate Cancer (link to abstract and commentaries)
Opinion: Cancer Treatment at Home is Safe, Effective, and Closer to Happening Than You Think
11 Feb, 2019 | 21:18h | UTCCancer treatment at home is safe, effective, and closer to happening than you think – STAT (free)
Related: The Oncology Hospital at Home – Journal of Clinical Oncology (free) AND Home care—a safe and attractive alternative to inpatient administration of intensive chemotherapies – Supportive Care in Cancer (free)
Population Screening for Cancer in High-Income Settings: Lessons for Low- and Middle-Income Economies – Journal of Global Oncology
11 Feb, 2019 | 21:15h | UTC
2019 NCCN Consensus Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma
11 Feb, 2019 | 21:05h | UTCRelated: FDA Report: 660 Cases of Breast Implant-Associated Anaplastic Large Cell Lymphoma (free report and commentaries)
FDA Report: 660 Cases of Breast Implant-Associated Anaplastic Large Cell Lymphoma
11 Feb, 2019 | 00:10h | UTCCommentary: FDA Emphasizes Lymphoma Risk in Women with Breast Implants – NEJM Journal Watch (free)
Related: Study: Long-term Outcomes of Silicone Breast Implants (link to abstract and commentary) AND Research: Breast Implants and the Risk of Anaplastic Large-Cell Lymphoma in the Breast (link to abstract and commentary) AND Breast Implant-Associated Anaplastic Large Cell Lymphoma (link to previous FDA report and commentaries)
Study: Web-Based Symptom Monitoring Increases Overall Survival in Lung Cancer
10 Feb, 2019 | 23:50h | UTCTwo-Year Survival Comparing Web-Based Symptom Monitoring vs Routine Surveillance Following Treatment for Lung Cancer – JAMA (link to abstract – $ for full-text)
Commentary: Lung cancer OS benefit with patient-reported symptom monitoring – Medwire News (free)
See Original Article: #ASCO2017 – Survival in a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Cancer Treatment (free study and commentaries)